Published in:
01-12-2014 | Erratum
Erratum to: Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma
Published in: Annals of Surgical Oncology | Special Issue 4/2014
Login to get accessExcerpt
Figure 1 was incorrect in the original article. The correct figure is as follows:
FIG. 1
The percentages of the viable HepJ5 and Mahlavu cells after treated with gemcitabine. a The survivin-KD and scrambled control Mahlavu cells (2 × 104 cells/well) were plated into 24-well plates with various dose of gemcitabine for 48 hours. The population survival cells were determined by MTT assay. b The survivin-KD and scrambled control HepJ5 cells were treated with various dose of gemcitabine for 48 hours. The population survival cells were determined by MTT assay. All the experiments were repeated at least 3 times independently. *P < 0.05
× ![]()
…